1. Kaolan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol 1995;154:1764-9.
2. Kurita Y, Ushiyama T, Suzuki K, Fujita K, Kawabe K. Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker. Int J Urol 1996;3:361-6.
3. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998;51:595-600.
4. Anderson JB, Roehrborn CG, Schalken JA, Emberton M. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 2001;39:390-9.
5. Slawin KM, Kattan MW. The use of Nomograms for selecting BPH candidates for dutasteride therapy. Rev Urol 2004;6(Suppl 9):S40-5.
6. Herbison AE, Fraundorfer MR, Walton JK. Association between symptomatology and uroflowmetry in benign pro-static hypertrophy. Br J Urol 1988;62:427-30.
7. Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995;153:1510-5.
8. Watanabe H. New concept of BPH: PCAR theory. Prostate 1998;37:116-25.
9. Keqin Z, Zhishun X, Jing Z, Haixin W, Dongqing Z, Benkang S. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology 2007;70:1096-9.
10. Doo CK, Uh HS. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS. Urology 2009;73:232-6.
11. Bang WJ, Kim HW, Lee JY, Lee DH, Hah YS, Lee HH, et al. Prostatic urethral angulation associated with urinary flow rate and urinary symptom scores in men with lower urinary tract symptoms. Urology 2012;80:1333-7.
12. Kwon JK, Han JH, Choi HC, Kang DH, Lee JY, Kim JH, et al. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia. BJU Int 2016;117:316-22.
13. Lee JH, Kim SH, Kang BJ, Choi JJ, Jeong SH, Yim HW, et al. Role and clinical usefulness of elastography in small breast masses. Acad Radiol 2011;18:74-80.
14. Schaefer FK, Heer I, Schaefer PJ, Mundhenke C, Osterholz S, Order BM, et al. Breast ultrasound elastog-raphy-results of 193 breast lesions in a prospective study with histopathologic correlation. Eur J Radiol 2011;77:450-6.
15. Cho N, Jang M, Lyou CY, Park JS, Choi HY, Moon WK. Distinguishing benign from malignant masses at breast US: combined US elastography and color doppler US-influence on radiologist accuracy. Radiology 2012;262:80-90.
17. Zhang M, Fu S, Zhang Y, Tang J, Zhou Y. Elastic modulus of the prostate: a new non-invasive feature to diagnose bladder outlet obstruction in patients with benign pro-static hyperplasia. Ultrasound Med Biol 2014;40:1408-13.
19. Sugimoto K, Matsumoto S, Uemura H, Ito H. Distribution of elastic fiber on prostate. Hinyokika Kiyo 2008;54:321-4.
20. Chagas MA, Babinski MA, Costa WS, Sampaio FJ. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate. BJU Int 2002;89:699-702.
23. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
24. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urologi-cal Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.